ascopubs.org

Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors

Data from 1,052 patients with aRCC treated on the CheckMate-214 phase III randomized trial with first-line nivolumab + ipilimumab or sunitinib were analyzed after minimum 5 years of follow-up. The end ...
The American Journal of Managed Care

Molecular Lesions in Low-Risk Myelodysplastic Neoplasms Disrupt Prognostic Model for Leukemia

Molecular lesion data in LR-MDS prognostic models reduce the significance of traditional parameters like bone marrow blast percentage. Molecular data altered risk stratification for 30% of patients, ...
EurekAlert!

An interpretable machine learning model for predicting 5‐year survival in breast cancer based on integration of proteomics and clinical data

n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...
EurekAlert!

Breakthrough in predicting cancer recurrence: AI model enhances prognostic accuracy with multi-omics integration

Predicting tumor recurrence at the molecular level emerges as a critical challenge, especially for patients with complex multi-omics profiles. Traditional prognostic models relying on single ...